DCR to present data on DaVita Cathaway program at ASN Annual Meeting

DaVita Clinical Research^® (DCR^®), a provider of clinical research and diagnostic laboratory services, announced today that 56 posters and five oral presentations will be presented by the Company's unsurpassed renal experts at the 43rd American Society of Nephrology (ASN) Annual Meeting and Scientific Exposition from November 16 - 21, 2010, at the Colorado Convention Center located in Denver, Colorado.

“We are very fortunate to have the opportunity to showcase our expertise and thought leadership. Our organization's devotion to this industry through research is what helps us excel.”

In DCR's presentation titled, "Catheter Reduction Reduces Hospitalization and Mortality," experts will discuss that following an aggressive catheter reduction initiative, such as the DaVita Cathaway™ program, decreases both central venous catheter (CVC) incidence and duration associated with significant decreased morbidity and mortality.

The DaVita^® network, including DaVita, Inc., DCR, and its renal-focused counterparts and partners were selected to represent a total of 56 posters and deliver five oral presentations. These numbers represent a notable presence by DaVita and the Company's related entities at ASN. While key abstracts are listed below, all represent impactful research showing great depth and presence at the meeting, as well as thought leadership.

The Effect of Sodium Thiosulfate (STS) on Measures of Mineral and Bone Disorders. Tracy J. Mayne, Tasos Constantin, Carey Colson, Mahesh Krishnan. DaVita, Inc. TH-PO132

The Effect of Pre-ESRD Care on Incident Patient Outcomes. Joe Weldon, Karen Spach, Mahesh Krishnan. DaVita, Inc. TH-PO451

Evaluating the Impact of Change in Pre-Dialysis Weight on a Change in Measured Hemoglobin. Joe Weldon, Tracy J. Mayne, Steve Wilson, Mahesh Krishnan. DaVita, Inc. TH-PO469

Determinants and Predictors of Successful Home Hemodialysis Training in a Multi-center US Observational Cohort. Christopher T. Chan, John Moran. Toronto General Hospital and DaVita, Inc. TH-FC125

Medication Non-Adherence Predicts Hospitalization Rate and Healthcare Costs in Hemodialysis (HD) Patients. Harold Manley, Steven Wang, Allen R. Nissenson. DaVita, Inc. F-PO1207

Comparative Effectiveness of Intravenous Vitamin D Agents. Carey Colson, Mahesh Krishnan, Tracy J. Mayne, Allen R. Nissenson. DaVita, Inc. F-PO1215

Hemodialysis (HD) Patients Utilizing Kidney Specialty Pharmacy Have Higher Medication Adherence, Fewer Hospitalizations and Lower Healthcare Costs. Harold Manley, Steven Wang, Allen R. Nissenson. DaVita, Inc. F-PO1507

Catheter Reduction Reduces Hospitalization and Mortality. Steve Wilson, Tracy J. Mayne, David Madigan, John Robertson, Janet Holland, Abbe Volz. DaVita, Inc. F-PO1576

Association of the Malnutrition-Inflammation Score (MIS) with First 90 Day Mortality in Incident Hemodialysis (HD) Patients. Debbie Benner, Kamyar Kalantar-Zadeh, Lilia Lukowsky, Steve Wilson, Kathy Lahr, Karen Spach, Mahesh Krishnan. DaVita, Inc. and Harold Simmons Center, Harbor-UCLA Medical Center. SA-PO2555

Focused Phosphorus Management Program Decreases Hyperphosphataemia in End Stage Renal Disease Patients. Tracy J. Mayne, Steve Wilson, Carey Colson, Kathy Ricketts. DaVita, Inc., and Shire. TH-PO155

"We are thrilled to be making such a statement at the ASN Annual Meeting with numerous presentations given by our high-caliber experts and thought leaders," stated DCR president Chris Rucker. "We are very fortunate to have the opportunity to showcase our expertise and thought leadership. Our organization's devotion to this industry through research is what helps us excel."

Source: DaVita Clinical Research